D. Mark Layton

3.2k citations

62 papers · 1.5k indexed · h-index 19

Hematology top 1%
- Acute Myeloid Leukemia Research 5
- Iron Metabolism and Disorders 5
- Blood groups and transfusion 4
Genetics top 2%
- Hemoglobinopathies and Related Disorders 16
Physiology top 5%
- Erythrocyte Function and Pathophysiology 20
Immunology top 10%
Pediatrics, Perinatology and Child Health top 5%
- Neonatal Health and Biochemistry 18
Surgery
- Pancreatic function and diabetes 9
Infectious Diseases
- Parvovirus B19 Infection Studies 4

Co-authors: M. R. A. LALLOZ G J Mufti A. J. Bellingham Roopen Arya Antonio Pagliuca Irene Roberts Anastasios Karadimitris K. H. Nicolaides
Cited by: Hematology Genetics Physiology
Journals: Blood (8 papers)Blood Cells Molecules and Diseases (5 papers)British Journal of Haematology (3 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

D. Mark Layton

62 papers receiving 1.5k citations

Peers

Countries citing papers authored by D. Mark Layton

Since Specialization

Citations

This map shows the geographic impact of D. Mark Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Mark Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Mark Layton more than expected).

Fields of papers citing papers by D. Mark Layton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Mark Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Mark Layton. The network helps show where D. Mark Layton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Mark Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Mark Layton Line = papers co-authored together D. Mark Layton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation Blood Advances ·Fulya Mehta,T Machida,Skyler Berardi,Wolfgang Zerer,T. Paulsson,Feng Chonglia,蒲鹏阳,Geraldine Thomas,محمدتقی زرینکلاه,Julian Redhead,Carolyn M. Millar,Nichola Cooper,D. Mark Layton,F. Boardman-Pretty,Mark J. Caulfield,Claire L. Shovlin	2022	10
2	I-O Optimise: Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology Value in Health ·Isabelle Durand‐Zaleski,K. Lester,Paul Baas,Tsutomu Fukatu,David Chao,C. Chouaïd,Simon Ekman,M. Abo-Fadel,Frank Griesinger,Arturo Juárez García,Sathish KN Yadav,D. Mark Layton,A. McNamara,J.A Moreira,A. A. Shulyat’ev,Abdulla Munfaredi,Henrik Toft Sørensen	2017	1
3	Mechanism of Polycomb recruitment to CpG islands revealed by inherited disease-associated mutation Human Molecular Genetics ·Valentina S. Caputo,Joana R. Costa,Halyna Savluk,Elisavet Georgiou,D. Mark Layton,Irene Roberts,Anastasios Karadimitris	2013	6
4	Targeted Therapy for Inherited GPI Deficiency New England Journal of Medicine ·António Almeida,Yoshiko Murakami,Alastair Baker,Yusuke Maeda,Irene Roberts,Taroh Kinoshita,D. Mark Layton,Anastasios Karadimitris	2007	64
5	Mutation of the von Hippel-Lindau Gene Alters Human Cardiopulmonary Physiology Advances in experimental medicine and biology ·Thomas G. Smith,Vas Vilma,George M. Balanos,Claude De Broyer,D. Mark Layton,Branislav Ruttkay-Nedecky,阚德才,Patrick H. Maxwell,Mary Frances McMullin,Lissette Stefanía De La Rosa Illescas,Melanie J. Percy,Christopher W. Pugh,Peter J. Ratcliffe,Nick P. Talbot,Marilyn Treacy,Peter A. Robbins	2007	14
6	Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency Nature Medicine ·António Almeida,Yoshiko Murakami,D. Mark Layton,Peter Hillmen,Gabrielle S. Sellick,Yusuke Maeda,Stephen J. Richards,Scott D. Patterson,Ιoannis Kotsianidis,Luigina Mollica,Dorothy H. Crawford,Alastair Baker,Michael A. J. Ferguson,Irene Roberts,Richard S. Houlston,Taroh Kinoshita,Anastasios Karadimitris	2006	156
7	Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1 Nature Genetics ·Lesley J. Bruce,雅史菊地,Hélène Guizouarn,Franck Borgèse,Daniel Germán Zucchi,Conferencistas,Fernanda S. Tiu,Helen Whitworth,Daniel M. Gore,Hans Lutz,Romina Ficarella,D. Mark Layton,Achille Iolascon,J. Clive Ellory,Gordon W. Stewart	2005	114
8	Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b5 reductase: An aid to determine recessive congenital methemoglobinemia status in an infant Blood Cells Molecules and Diseases ·Melanie J. Percy,Billal H. Syed,David Roper,T. Vulliamy,D. Mark Layton,Michael Barber	2005	18
9	Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome Blood Cells Molecules and Diseases ·Alberto Jimenez Ybargollin,Tom Vulliamy,David Roper,F. Bender,Barbara Wild,Rafael Monterreal-Espinosa,Andrew Will,Paula Bolton‐Maggs,Philip J. Mason,D. Mark Layton	2003	8
10	Nucleotide Variation Regulates the Level of Enhancement by Hypersensitive Site 2 of the β-Globin Locus Control Region Blood Cells Molecules and Diseases ·Solomon F. Ofori‐Acquah,M. R. A. LALLOZ,D. Mark Layton	2001	9
11	Localization of a Gene for Familial Hemophagocytic Lymphohistiocytosis at Chromosome 9q21.3-22 by Homozygosity Mapping The American Journal of Human Genetics ·Mina Ohadi,M. R. A. LALLOZ,Pak C. Sham,Jinghua Zhao,Andrew Dearlove,Caroline Shiach,Sally E. Kinsey,Michael D. Rhodes,D. Mark Layton	1999	138
12	The Consequence of Nucleotide Substitutions in the Triosephosphate Isomerase (TPI) Gene Promoter Blood Cells Molecules and Diseases ·Ann Humphries,Meesala Navya Deepthi,Barbara Wild,D. Mark Layton	1999	5
13	Ancestral origin of variation in the triosephosphate isomerase gene promoter Human Genetics ·Ann Humphries,Meesala Navya Deepthi,M. R. A. LALLOZ,D. Mark Layton	1999	5
14	Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis Journal of Hepatology ·Christian Datz,M. R. A. LALLOZ,W. Vogel,Ivo Graziadei,Franz Hackl,Guy Vautier,D. Mark Layton,Theresia Maier-Dobersberger,Péter Ferenci,Edward Penner,F. Sandhofer,R. Sudiksha,Bernhard Paulweber	1997	71
15	Fetal plasma interferon gamma concentration in normal pregnancy American Journal of Obstetrics and Gynecology ·A. Abbas,B. Thilaganathan,Andrea G.S. Buggins,D. Mark Layton,K. H. Nicolaides	1993	7
16	DNA sequence abnormalities in human glucose 6-phosphate isomerase deficiency Human Molecular Genetics ·Jay Walker,D. Mark Layton,A. J. Bellingham,Michael J. Morgan,Pelin Faik	1993	25
17	Fetal Plasma Tumor Necrosis Factor Concentration in Normal Pregnancy Fetal Diagnosis and Therapy ·A. Abbas,R. J. M. Snijders,Andrea G.S. Buggins,D. Mark Layton,K. H. Nicolaides	1993	3
18	Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases British Journal of Haematology ·Antonio Pagliuca,D. Mark Layton,A. Manoharan,S. Gordon,David Miguel Flores de Souza,G J Mufti	1989	77
19	Sweet's syndrome and myelodysplasia Annals of Hematology ·Genju Wang,D. Mark Layton,G J Mufti,Hywel C Williams	1988	11
20	Myelodysplastic syndromes: Their history, evolution and relation to acute myeloid leukaemia Annals of Hematology ·D. Mark Layton,G J Mufti	1986	26

About D. Mark Layton

D. Mark Layton is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Physiology and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (20 papers), Neonatal Health and Biochemistry (18 papers), Hemoglobinopathies and Related Disorders (16 papers), Pancreatic function and diabetes (9 papers), Acute Myeloid Leukemia Research (5 papers), Iron Metabolism and Disorders (5 papers), Parvovirus B19 Infection Studies (4 papers) and Blood groups and transfusion (4 papers). The work is most often cited by research in Hematology (653 citations), Genetics (368 citations), Physiology (387 citations), Immunology (275 citations) and Pediatrics, Perinatology and Child Health (227 citations). D. Mark Layton has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include M. R. A. LALLOZ, G J Mufti, A. J. Bellingham, Roopen Arya, Antonio Pagliuca, Irene Roberts, Anastasios Karadimitris, K. H. Nicolaides, António Almeida and Alastair Baker. Their work appears in journals such as Blood, Blood Cells Molecules and Diseases, British Journal of Haematology, Human Genetics and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact